Iambic Launches Enchant v3 – Molecular Superintelligence Designed to Advance End-to-End Drug Discovery & Development
Iambic official newsroom · Indexed industry source record · Source published: Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:09 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Enchant v3 is the next generation of Iambic’s multimodal transformer model, trained using 41 billion parameters on more than 6,000 molecular properties across 16 biomedical data modalities Enchant v3 ingests diverse datasets, deploys a mixture-of-experts architecture, and tests multiple hypotheses in parallel to optimize discovery and development decisions San Diego – Sept. 21, 2026 – Iambic, a cl
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.